AI assistant
Sending…
CORCEPT THERAPEUTICS INC — Director's Dealing 2016
Jul 25, 2016
30681_dirs_2016-07-25_083d227b-c9a5-455a-be4a-b3c690e3f8d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-07-21
Reporting Person: ENRIGHT PATRICK G (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-21 | Stock Option (Right to Buy) | $5.86 | A | 30000 | Acquired | 2026-07-21 | Common Stock (30000) | Direct |
Footnotes
F1: The vesting period of the shares underlying the option award commenced on June 27, 2016, with 8.3334% of the shares to vest on each monthly anniversary of the grant date until all shares are vested. The reporting person shares pecuniary interest in these securities with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership of these securities except as to the extent of the reporting person's pecuniary interest in these securities.
More from CORCEPT THERAPEUTICS INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 18